Long-term evaluation of the randomized ASPREE trial and an observational follow-up study confirmed prior results that low-dose aspirin did not reduce cancer incidence among older adults and ...
People living with complex chronic conditions are poorly served by our health-care system, which was designed to care for acute illness.